1. Home
  2. VTMX vs PBLS Comparison

VTMX vs PBLS Comparison

Compare VTMX & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

VTMX

Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

HOLD

Current Price

$33.95

Market Cap

3.2B

Sector

N/A

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$37.76

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VTMX
PBLS
Founded
1998
N/A
Country
Mexico
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.6B
IPO Year
2023
2026

Fundamental Metrics

Financial Performance
Metric
VTMX
PBLS
Price
$33.95
$37.76
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$40.00
N/A
AVG Volume (30 Days)
54.3K
363.6K
Earning Date
04-23-2026
N/A
Dividend Yield
2.01%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.22
N/A
Revenue Next Year
$11.52
N/A
P/E Ratio
$47.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.59
$25.56
52 Week High
$37.41
$37.83

Technical Indicators

Market Signals
Indicator
VTMX
PBLS
Relative Strength Index (RSI) 47.21 65.69
Support Level $33.54 $26.42
Resistance Level $35.10 N/A
Average True Range (ATR) 0.66 2.40
MACD -0.02 0.22
Stochastic Oscillator 28.57 93.64

Price Performance

Historical Comparison
VTMX
PBLS

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: